ibandronic acid has been researched along with Femoral Fractures in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hadjiargyrou, M | 1 |
Espey, R; Grimes, S; Heyburn, G; Kealey, WD | 1 |
Chen, W; Dong, T; Guo, J; Hou, Z; Jin, L; Ju, L; Li, J; Liu, B; Liu, Y; Tian, Y; Zhang, F; Zhang, Q; Zhang, Y | 1 |
Ju, JH; Jung, SM; Koh, JH; Kwok, SK; Lee, J; Myong, JP; Park, SH | 1 |
Ataoğlu, B; Berkay, AF; Eren, TK; Kaptan, AY; Yapar, AE | 1 |
Lazzarini, AM; Patel, VC | 1 |
Cheung, WH; Chow, DH; Leung, AH; Leung, KS; Qin, L | 1 |
Iwata, K; Kaji, Y; Komatsubara, S; Manabe, T; Mashiba, T; Mori, S; Yamamoto, T | 1 |
Bauss, F; Eberhardt, C; Habermann, B; Kurth, AH; Müller, S; Schwarz, M | 1 |
Skoglund, B | 1 |
1 review(s) available for ibandronic acid and Femoral Fractures
Article | Year |
---|---|
Effects of bisphosphonates on appendicular fracture repair in rodents.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Estrogens; Femoral Fractures; Fractures, Stress; Glucocorticoids; Ibandronic Acid; Mice; Rats; Rodentia | 2022 |
9 other study(ies) available for ibandronic acid and Femoral Fractures
Article | Year |
---|---|
The first reported case of Atypical Femoral Fracture caused by daily ibandronate prescribed for bone metastases in breast cancer.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Nails; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Diphosphonates; Female; Femoral Fractures; Humans; Ibandronic Acid; Middle Aged | 2017 |
Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats.
Topics: Animals; Biomarkers; Bone Remodeling; Collagen; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Femoral Fractures; Fracture Healing; Ibandronic Acid; Ovariectomy; Rats; Rats, Sprague-Dawley | 2017 |
Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Femoral Fractures; Femur; Genu Valgum; Humans; Ibandronic Acid; Logistic Models; Lumbar Vertebrae; Middle Aged; Multivariate Analysis; Osteoporotic Fractures; Retrospective Studies; Risedronic Acid; Risk Factors; Time Factors | 2016 |
Atypical femoral fracture following zoledronic acid treatment.
Topics: Absorptiometry, Photon; Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Femoral Fractures; Fracture Fixation; Humans; Ibandronic Acid; Imidazoles; Magnetic Resonance Imaging; Osteoporosis; Treatment Outcome; Withholding Treatment; Zoledronic Acid | 2016 |
Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
Topics: Aged; Bone Density Conservation Agents; Bone Development; Bone Nails; Diphosphonates; Female; Femoral Fractures; Fracture Fixation, Internal; Fracture Healing; Humans; Ibandronic Acid; Multiple Trauma; Radiography | 2010 |
Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing.
Topics: Animals; Bone Remodeling; Bony Callus; Diphosphonates; Female; Femoral Fractures; Fracture Healing; Ibandronic Acid; Osteocalcin; Osteoclasts; Osteoporotic Fractures; Random Allocation; Rats; Rats, Sprague-Dawley; Vibration; X-Ray Microtomography | 2011 |
Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Femoral Fractures; Femur; Fracture Healing; Ibandronic Acid; Osteotomy; Radiography; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2012 |
The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Topics: Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Disease Models, Animal; Durapatite; Female; Femoral Fractures; Ibandronic Acid; Injections, Subcutaneous; Osseointegration; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2007 |
Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Disease Models, Animal; Femoral Fractures; Fracture Healing; Fractures, Bone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Injections, Subcutaneous; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Simvastatin | 2007 |